Amlodipine plus Losartan
Amlodipine plus Losartan is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Pharmacokinetic Interaction Between Amlodipine and Losartan
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension
Clinical Trials (6)
The Pharmacokinetic Interaction Between Amlodipine and Losartan
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension
Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6